To identify key characteristics of the tissue resident and peripherally circulating immune-phenotype in addition to blood markers, metabolic profile, faecal and oral microbiota in non-alcoholic fatty liver disease
Age ≥18 years
Confirmed non-alcoholic Fatty liver disease (diagnosed clinically, radiologically or histologically)
If diabetic, Diagnosed with Type 2 Diabetes Mellitus
Unwilling or unable to give informed consent
Type 1 Diabetes Mellitus
Other form of liver disease (other than NAFLD)
Taking medication associated with liver dysfunction (except methotrexate)
Queen Mary University of London
Lead sponsor
Homerton University Hospital NHS Foundation Trust
Collaborator
Barts & The London NHS Trust
Collaborator
King's College Hospital NHS Trust
Collaborator